Back
ESC Premium Access

Diminished response to statin therapy predicts future occurrence of heart failure in patients with acute myocardial infarction

Session: Poster Session 1 - Chronic heart failure – Treatment
Topic: Pharmacotherapy
Speaker: Doctor K. Tsuda (Takatsuki, JP)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Kosuke Tsuda

Osaka Medical and Pharmaceutical University, Takatsuki (Japan)
1 presentation
0 follower

7 more presentations in this session

Early commencement of tolvaptan therapy improves clinical outcomes in heart failure patients with preserved function of renal vasopressin V2 receptors

Speaker: Doctor T. Noto (Sapporo, JP)

Access
Abstract
Thumbnail

Research into the effect of sodium-glucose linked transporter inhibition in left ventricular remodelling in patients with heart failure and diabetes mellitus.

Speaker: Professor C. Lang (Dundee, GB)

Access
Abstract
Thumbnail

Titration patterns and clinical characteristics of patients prescribed sacubitril/valsartan in the primary care and cardiology settings in germany

Speaker: Associate Professor R. Wachter (Leipzig, DE)

Access
Abstract
Slides
Thumbnail

Characteristics of heart failure patients treated with Sacubitril - Valsartan in Europe. Results from ARIADNE

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Access
Abstract
Thumbnail

Heart rate reduction by selective sinus node blocker (ivabradine) protects against detrimental hemodynamic and structural effects of iv inotrops in heart failure

Speaker: Professor P. Leszek (Warsaw, PL)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 1 - Chronic heart failure – Treatment

Speakers: Doctor K. Tsuda, Doctor T. Noto, Professor C. Lang, Associate Professor R. Wachter, Professor U. Zeymer...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb